We detected an increasing trend in new INH-R cases, 10.9%, compared to 2014 (9.2%) [ 5 ] driven by a higher percentage of INH-R non-MDR strains (7.6% in 2018 vs 5.5% in 2014).
← all excerpts
Monitoring of First-line Drug Resistance Mutations Outside the Scope of Xpert MTB/RIF Ultra is Needed for Successful Control of DR-TB in Southern Mozambique.
1
—
—